Medication-related clinical decision support in computerized provider order entry systems: a review

GJ Kuperman, A Bobb, TH Payne… - Journal of the …, 2007 - academic.oup.com
While medications can improve patients' health, the process of prescribing them is complex
and error prone, and medication errors cause many preventable injuries. Computer provider …

The pharmacokinetics of paliperidone versus risperidone

J de Leon, G Wynn, NB Sandson - Psychosomatics, 2010 - Elsevier
Background Several new atypical antipsychotics have become available for use, but
knowledge about their pharmacology may not be widespread. Objective This review aims to …

Trends in use of high-intensity statin therapy after myocardial infarction, 2011 to 2014

RS Rosenson, ME Farkouh, M Mefford, V Bittner… - Journal of the American …, 2017 - jacc.org
Background: Data prior to 2011 suggest that a low percentage of patients hospitalized for
acute coronary syndromes filled high-intensity statin prescriptions upon discharge. Black …

A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care

R Tamblyn, A Huang, L Taylor… - Journal of the …, 2008 - academic.oup.com
Objectives: Prescribing alerts generated by computerized drug decision support (CDDS)
may prevent drug-related morbidity. However, the vast majority of alerts are ignored …

Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS)

KB Hoffman, AR Demakas, M Dimbil, NP Tatonetti… - Drug safety, 2014 - Springer
Abstract Background The US Food and Drug Administration (FDA) uses the Adverse Event
Reporting System (FAERS) to support post-marketing safety surveillance programs …

Existence of notoriety bias in FDA adverse event reporting system database and its impact on signal strength

R Neha, V Subeesh, E Beulah, N Gouri… - Hospital …, 2021 - journals.sagepub.com
Background: Notoriety bias is defined as “a selection bias in which a case has a greater
chance of being reported if the subject is exposed to the studied factor known to cause …

Safety of medication use in primary care

JO Olaniyan, M Ghaleb, S Dhillon… - International Journal of …, 2015 - academic.oup.com
Background Medication errors are one of the leading causes of harmin health care. Review
and analysis of errors have often emphasized their preventable nature and potential for …

[图书][B] Using mass spectrometry for drug metabolism studies

WA Korfmacher - 2009 - taylorfrancis.com
The first edition of this now classic work helped to establish mass spectrometry as the
premier tool for drug metabolism studies. Completely rewritten from start to finish, Using …

A secure distributed logistic regression protocol for the detection of rare adverse drug events

K El Emam, S Samet, L Arbuckle… - Journal of the …, 2013 - academic.oup.com
Background There is limited capacity to assess the comparative risks of medications after
they enter the market. For rare adverse events, the pooling of data from multiple sources is …

Methodological gaps in the assessment of risk minimization interventions: a systematic review

I Gridchyna, AM Cloutier, L Nkeng… - … and drug safety, 2014 - Wiley Online Library
Introduction Since the introduction of therapeutic risk management regulatory guidance, an
increase in the number of risk minimization interventions (RMIs) published in the literature …